- Home
- IMNN vs FTEL Comparison
IMNN vs FTEL Comparison
Compare IMNN & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- FTEL
- Stock Information
- Founded
- IMNN 1982
- FTEL 2007
- Country
- IMNN United States
- FTEL Australia
- Employees
- IMNN N/A
- FTEL N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- FTEL
- Sector
- IMNN Health Care
- FTEL
- Exchange
- IMNN Nasdaq
- FTEL Nasdaq
- Market Cap
- IMNN 12.1M
- FTEL 9.8M
- IPO Year
- IMNN 1985
- FTEL 2023
- Fundamental
- Price
- IMNN $6.53
- FTEL $0.46
- Analyst Decision
- IMNN Buy
- FTEL
- Analyst Count
- IMNN 2
- FTEL 0
- Target Price
- IMNN $182.61
- FTEL N/A
- AVG Volume (30 Days)
- IMNN 244.8K
- FTEL 121.5K
- Earning Date
- IMNN 08-05-2025
- FTEL 04-28-2025
- Dividend Yield
- IMNN N/A
- FTEL N/A
- EPS Growth
- IMNN N/A
- FTEL N/A
- EPS
- IMNN N/A
- FTEL N/A
- Revenue
- IMNN N/A
- FTEL $4,990,695.00
- Revenue This Year
- IMNN N/A
- FTEL N/A
- Revenue Next Year
- IMNN N/A
- FTEL N/A
- P/E Ratio
- IMNN N/A
- FTEL N/A
- Revenue Growth
- IMNN N/A
- FTEL 29.02
- 52 Week Low
- IMNN $4.83
- FTEL $0.36
- 52 Week High
- IMNN $41.22
- FTEL $49.50
- Technical
- Relative Strength Index (RSI)
- IMNN 40.89
- FTEL 40.03
- Support Level
- IMNN $6.17
- FTEL $0.44
- Resistance Level
- IMNN $7.21
- FTEL $0.50
- Average True Range (ATR)
- IMNN 0.51
- FTEL 0.04
- MACD
- IMNN 0.14
- FTEL -0.00
- Stochastic Oscillator
- IMNN 20.45
- FTEL 19.75
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.